Literature DB >> 25106090

Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes.

T Elgzyri1, J Larsson2, P Nyberg3, J Thörne4, K-F Eriksson5, J Apelqvist6.   

Abstract

OBJECTIVES: There is limited information about whether time from recognition of decreased perfusion to revascularization affects the probability of healing in a patient with a diabetic foot ulcer. The aim of the present study was to examine whether time to revascularization after referral to a multidisciplinary foot center was related to the outcome of foot ulcers in patients with diabetes and severe peripheral arterial disease (PAD).
METHODS: Patients with diabetes, a foot ulcer, and a systolic toe pressure <45 mmHg or an ankle pressure <80 mmHg were prospectively included at the foot center, and considered for revascularization according to a preset protocol. All patients underwent invasive revascularization, either percutaneous transluminal angioplasty (PTA) or reconstructive vascular surgery. All patients had continuous follow-up until healing or death irrespective of the type of revascularization.
RESULTS: A total of 478 patients were included (age 74 [range 66-80] years, 60% males), of whom 315 patients (66%) had PTA, and 163 (34%) had reconstructive surgery. Of the 478 patients, 217 (45%) healed primarily, 88 (19%) healed after a minor amputation, 76 (16%) healed after a major amputation and 92 patients (19%) died unhealed. The median time from inclusion in the study to revascularization was 8 weeks (3-18 weeks). Time to vascular intervention within 8 weeks (p < .001), maximum Wagner grade reached <3 (p < .001), absence of peripheral edema (p = .033), and presence of intermittent claudication (p = .001) were related to a higher probability of healing.
CONCLUSIONS: Time to revascularization and extent of tissue damage were related to the probability of healing of ischemic foot ulcer in patients with diabetes over time. In the presence of a decreased perfusion in a patient with diabetes and a foot ulcer not only revascularization per se but also timing of revascularization is important for the possibility of healing without a major amputation.
Copyright © 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Foot ulcer; Time to revascularization

Mesh:

Year:  2014        PMID: 25106090     DOI: 10.1016/j.ejvs.2014.06.041

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  12 in total

Review 1.  Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.

Authors:  Vivienne Chuter; Frank Quigley; Patrik Tosenovsky; Jens Carsten Ritter; James Charles; Jane Cheney; Robert Fitridge
Journal:  J Foot Ankle Res       Date:  2022-07-05       Impact factor: 3.050

Review 2.  Promoting Limb Salvage through Multi-Disciplinary Care of the Diabetic Patient.

Authors:  Nichol L Salvo; Mark D Walsh; Luke P Brewster
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-07

3.  Reversible secretome and signaling defects in diabetic mesenchymal stem cells from peripheral arterial disease patients.

Authors:  Tatiana Chadid; Andrew Morris; Alexandra Surowiec; Scott Robinson; Maiko Sasaki; Jacques Galipeau; Brian P Pollack; Luke P Brewster
Journal:  J Vasc Surg       Date:  2018-08-10       Impact factor: 4.268

4.  Angioplasty and stenting for below the knee ulcers in diabetic patients: protocol for a systematic review.

Authors:  Carolina Dutra Queiroz Flumignan; Fábio Cabral Freitas Amaral; Ronald Luiz Gomes Flumignan; Vladimir Tonello Vasconcelos; Gabriela Araújo Attie; Raul Muffato Daolio; Henrique Jorge Guedes-Neto; Jorge Eduardo de Amorim; José Carlos Costa Baptista-Silva; Luis Carlos Uta Nakano
Journal:  Syst Rev       Date:  2018-12-11

5.  Can we predict vascular status and culture result based through wound status in diabetic foot infection?

Authors:  Jin Yong Shin; Si-Gyun Roh; Suk Choo Chang; Nae-Ho Lee
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

6.  Development of the Tardivo Algorithm to Predict Amputation Risk of Diabetic Foot.

Authors:  João Paulo Tardivo; Maurício S Baptista; João Antonio Correa; Fernando Adami; Maria Aparecida Silva Pinhal
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

7.  Management of peripheral arterial disease in diabetes: a national survey of podiatry practice in the United Kingdom.

Authors:  Pasha Normahani; Chira Mustafa; Nigel J Standfield; Claire Duguid; Martin Fox; Usman Jaffer
Journal:  J Foot Ankle Res       Date:  2018-06-08       Impact factor: 2.303

8.  Outcome of intra-arterial thrombolysis in patients with diabetes and acute lower limb ischemia: a propensity score adjusted analysis.

Authors:  Talha Butt; Anders Gottsäter; Jan Apelqvist; Gunnar Engström; Stefan Acosta
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

9.  Effectiveness of a multicenter training programme to teach point-of-care vascular ultrasound for the detection of peripheral arterial disease in people with diabetes.

Authors:  Pasha Normahani; Rishi Agrawal; Vasilliki Bravis; Agnieszka Falinska; Linda Bloomfield; Zaheer Mehar; Dawn Gaulton; Alex Sangster; Tracey Arkle; Corinna Gomm; Mohamed Aslam; Nigel J Standfield; Usman Jaffer
Journal:  J Foot Ankle Res       Date:  2018-07-16       Impact factor: 2.303

10.  Netrin-1 improves adipose-derived stem cell proliferation, migration, and treatment effect in type 2 diabetic mice with sciatic denervation.

Authors:  Xing Zhang; Jinbao Qin; Xin Wang; Xin Guo; Junchao Liu; Xuhui Wang; Xiaoyu Wu; Xinwu Lu; Weimin Li; Xiaobing Liu
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.